The impact of chronic kidney disease on global health.
EF Carney - Nature Reviews Nephrology, 2020 - go.gale.com
EF Carney
Nature Reviews Nephrology, 2020•go.gale.comThe Global Burden of Disease (GBD) study 2017 quantified the contribution of 354 diseases
and injuries and 84 risk factors to morbidity and mortality in 195 countries and territories
between 1990 and 2017. A new analysis based on this study estimates morbidity and
mortality owing to chronic kidney disease (CKD) and impaired kidney function at the global,
regional and national levels." The main aim of the GBD study is to provide policy makers
worldwide with up-to-date information on health outcomes that are comparable between …
and injuries and 84 risk factors to morbidity and mortality in 195 countries and territories
between 1990 and 2017. A new analysis based on this study estimates morbidity and
mortality owing to chronic kidney disease (CKD) and impaired kidney function at the global,
regional and national levels." The main aim of the GBD study is to provide policy makers
worldwide with up-to-date information on health outcomes that are comparable between …
The Global Burden of Disease (GBD) study 2017 quantified the contribution of 354 diseases and injuries and 84 risk factors to morbidity and mortality in 195 countries and territories between 1990 and 2017. A new analysis based on this study estimates morbidity and mortality owing to chronic kidney disease (CKD) and impaired kidney function at the global, regional and national levels.
" The main aim of the GBD study is to provide policy makers worldwide with up-to-date information on health outcomes that are comparable between diseases, combining information on deaths and non-fatal disease," explains Boris Bikbov, co-corresponding author on the new analysis." The United Nations sustainable development goals aim to reduce premature mortality from non-communicable diseases by one-third by 2030, and our estimates suggest that targeting CKD will be an important consideration for reaching these goals."
![](/scholar/images/qa_favicons/galegroup.com.png)